HIND Vyome Holdings, Inc.

NASDAQ
$1.58

Vyome Holdings, Inc. (HIND) is expected to report earnings on February 11, 2027, before the market open. The stock has had a Post-Earnings Announcement Drift (PEAD) of +0.6% since its last earnings release on November 12, 2026.

Vyome Reported Earnings
Monday, November 16, 2026 · 8:32 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 11
Thursday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.61

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Vyome Holdings, Inc.

Vyome Therapeutics Inc. is a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases principally in the US. Vyome Therapeutics Inc., formerly known as ReShape Lifesciences Inc., is based in CAMBRIDGE, Mass.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Charts powered in part by Lightweight Charts™ by TradingView.